首页> 外文OA文献 >Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)

【2h】

Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)

机译：IGA肾病患者实施肾脏健康倡议蛋白疗效终点（保护试验）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jonathan Barratt; Brad Rovin; Ulysses Diva; Alex Mercer; Radko Komers;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial) [J] . Jonathan Barratt, Brad Rovin, Ulysses Diva, Kidney International Reports . 2019,第11期

机译：实施肾脏健康计划以替代IgA肾病患者的功效终点（PROTECT试验）
2. Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial) [J] . Jonathan Barratt, Brad Rovin, Ulysses Diva, Kidney International Reports . 2019,第11期

机译：实施肾脏健康计划以替代IgA肾病患者的功效终点（PROTECT试验）
3. Perspectives on optimizing trial design and endpoints in peripheral arterial disease: a case for imaging-based surrogates as endpoints of functional efficacy. [J] . Rajagopalan S, Mihai G Cardiology clinics . 2011,第3期

机译：优化外围动脉疾病的试验设计和终点的观点：基于影像的替代物作为功能功效终点的案例。
4. Patient in control in clinical trials - European initiatives for improving patient empowerment in clinical trials through technical implementation of legal norms [C] . Forgo Nikolaus, Goralczyk Magdalena, Hanold Stefanie Annual Conference of Japanese Society for Medical and Biological Engineering;Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2013

机译：在临床试验中控制患者-通过法律规范的技术实施来提高临床试验中患者的能力的欧洲倡议
5. Statistical methods for identifying surrogate endpoints in vaccine trials. [D] . Wolfson, Julian. 2009

机译：在疫苗试验中识别替代终点的统计方法。
6. Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial) [O] . Jonathan Barratt, Brad Rovin, Ulysses Diva, 2019

机译：实施肾脏健康计划以替代IgA肾病患者的功效终点（保护试验）
7. Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy. [O] . Yong-Chul Kim, Ho Jun Chin, Ho Suk Koo, 2013

机译：他克莫司可降低Iga肾病和正常血压患者的白蛋白尿：一项关于他克莫司对Iga肾病疗效的双盲随机对照试验。

Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)

著录项

引文网络

相似文献

相关主题

期刊订阅